IP36-03: CDK4/6 Inhibition Induces Fibroblast-Mediated CD8+ T Cell Trafficking in Muscle-Invasive Bladder Cancer (MIBC): Mechanistic Rationale for Sequential Therapy with Enfortumab Vedotin-Pembrolizumab (EV-P)

IP36-03: CDK4/6 Inhibition Induces Fibroblast-Mediated CD8+ T Cell Trafficking in Muscle-Invasive Bladder Cancer (MIBC): Mechanistic Rationale for Sequential Therapy with Enfortumab Vedotin-Pembrolizumab (EV-P)

Saturday, May 16, 2026 9:30 AM to 11:30 AM · 1 hr. 59 min. (America/New_York)
147B
Abstract

Log in

See all the content and easy-to-use features by logging in or registering!